Rhea Dapagliflozin Indications/Uses

Type 2 diabetes mellitus: Dapagliflozin is indicated in adults with type 2 diabetes mellitus for: the treatment of diabetes as an adjunct to diet and exercise. Dapagliflozin can be given as monotherapy or in combination with other medicinal products indicated for the treatment of type 2 diabetes mellitus (see Pharmacology: Pharmacodynamics under Actions).
The prevention of new or worsening heart failure or cardiovascular death (see Pharmacology: Pharmacodynamics under Actions).
The prevention of new or worsening nephropathy (see Pharmacology: Pharmacodynamics under Actions).
Heart failure: Dapagliflozin is indicated in adults for the treatment of heart failure with reduced ejection fraction (see Pharmacology: Pharmacodynamics under Actions).
Chronic kidney disease: Dapagliflozin is indicated in adults for the treatment of chronic kidney disease (see Pharmacology: Pharmacodynamics under Actions).
Limitations of Use: Dapagliflozin is not indicated for use in patients with type 1 diabetes.
Dapagliflozin should not be used for the treatment of diabetic ketoacidosis.